Malaria Antibody, IgG
Malaria is a febrile illness caused by one of five species of the protozoan parasite, Plasmodium (P. malariae, P. vivax, P. falciparum, P. ovale and the recently identified P. knowlesi). Malaria is endemic in most tropical and subtropical climates where it infects over 200 million people annually and causes over 400,000 deaths. The symptoms of malaria are dependent on the Plasmodium sp. involved, the age of the individual and their level of immunity.
P. vivax and P. falciparum are the species most commonly encountered in patients with malaria. P. knowlesi rarely causes infections in humans. Infection with P. falciparum may be associated with fatal complications involving the brain and multiple organs. Infection with multiple species may also be encountered.
Humans acquire malaria via the bite of an infected female Anopheles mosquito. During feeding sporozoites, the infective stage of the parasite, are inoculated into the blood. The sporozoites then invade hepatocytes and erythrocytes, multiply by forming numerous merozoites which are then released to infect more cells when the hepatocytes and erythrocytes die. Patients usually develop symptoms after an incubation period of 7-30 days. The clinical manifestations are the result of large numbers of merozoites in the blood released after the erythrocytic stage. Symptoms include fever with chills, headache, muscle aches, and sometimes hemolytic anemia with jaundice. Untreated P. falciparum infections can lead to cerebral malaria and cause seizures and coma. Older aged individuals, those with poor nutrition, and individuals with immunodeficiency are vulnerable to develop severe disease. Glucose-6 Phosphate Dehydrogenase (G6PD) enzyme deficiency and Sickle Cell Trait are known to provide some protection against malaria.
The examination of Giemsa-stained peripheral blood films is routinely performed for the primary screening and diagnosis of malaria. Although microscopy is fairly sensitive at detecting malaria, species identification can be very difficult even with practiced observers. Molecular detection of the parasite using PCR is an efficient for both diagnosis as well as species identification of malaria. In addition, antibody IgG assay to plasmodium malaria has been developed and can be used to evaluate the infection status,.
- As an aid in the diagnosis of malaria
- Immune status to malaria
Positive results for IgG antibody to malaria would indicate current or past infection.
Negative results for IgG antibody to malaria would indicate no immunity or infection.
Negative
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (red top tube).
Stability
- Ambient: 3-5 days.
- Refrigerated: 7-14 days
- Frozen: unstable
- Malaria. StatPearls Publishing [PMID: 31869175]
- Cold Spring Harb Perspect Med. 2018; 1:a025569 [PMID: 28533315]
- Denise L. Doolan. Malaria Methods and Protocols. Methods in Molecular Medicine. 2002. Humana Press.Inc